Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Sep 26, 2024; 12(27): 6057-6069
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6057
Table 3 Analysis of the risk of recurrence within 1 year using a simple logistic regression model
Parameter
Crude OR (95%CI)
P value
Age in yr
    ≥ 550.546 (0.222, 1.343)0.188
    < 551.000
Sex
    Female0.662 (0.261, 1.681)0.386
    Male1.000
Previous systemic therapy
    Any1.603 (0.574, 4.482)0.368
    Never1.000
Clinical presentation
    Primary1.210 (0.500, 2.931)0.673
    Recurrence1.000
Cancer type
    Ovary0.646 (0.239, 1.746)0.389
    GI 1.000
CC score
    00.141 (0.037, 0.541)0.004a
    11.000
PCI score
    1-70.444 (0.180, 1.095)0.078
    8-391.000
HIPEC regimen
    Cisplatin1.778 (0.657, 4.809)0.257
    Non-cisplatin1.000
HIPEC duration in min
    ≤ 60 1.565 (0.632, 3.879)0.333
    90 1.000
Extraperitoneal oligometastasis
    Any1.071 (0.401, 2.830)0.890
    None1.000
Surgical method
    Laparoscopy0.858 (0.239, 3.077)0.814
    Laparotomy1.000
Histology grade
    Grade 1/20.656 (0.270, 1.597)0.353
    Grade 31.000
Pre-HIPEC chemotherapy1
    Yes2.259 (0.922, 5.532)0.075
    No1.000
Post-HIPEC chemotherapy2
    Yes1.500 (0.389, 5.781)0.556
    No1.000
CRS time in h
    ≤ 6 0.361 (0.146, 0.892)0.027a
    > 6 1.000
Bowel resection
    Yes2.143 (0.858, 5.351)0.103
    No1.000